Kunihiro Asanuma (Yumiko Asanuma)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Coronary Artery Bypass

Finite Element Analysis

Radiofrequency Ablation

Top Venues

Cancer management and research

Journal of surgical case reports

Communicative & integrative biology

Orthopaedic surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Kouji Kita, Kunihiro Asanuma, Takayuki Okamoto, Eiji Kawamoto, Koichi Nakamura, Tomohito Hagi, Tomoki Nakamura, Motomu Shimaoka, Akihiro Sudo
A Novel Approach to Reducing Lung Metastasis in Osteosarcoma: Increasing Cell Stiffness with Carbenoxolone. Current issues in molecular biology 45 (5) (2023)
Kunihiro Asanuma, Gaku Miyamura, Yoshiaki Suzuki, Yoshinori Makino, Naoya Takada, Haruhiko Satonaka, Kakunoshin Yoshida, Tomohito Hagi, Tomoki Nakamura, Akihiro Sudo
New screw technique for posterior column and ischial fixation from the anterior approach for acetabular fractures. Journal of surgical case reports 2023 (2) (2023)
Kunihiro Asanuma, Gaku Miyamura, Yoshiaki Suzuki, Yoshinori Makino, Naoya Takada, Haruhiko Satonaka, Kakunoshin Yoshida, Tomohito Hagi, Tomoki Nakamura, Akihiro Sudo
New screw technique for posterior column and ischial fixation from the anterior approach for acetabular fractures. Journal of surgical case reports 2023 (2) (2023)
Kunihiro Asanuma, Tomoki Nakamura, Takahiro Iino, Tomohito Hagi, Akihiro Sudo
Macrophages and vimentin in tissues adjacent to megaprostheses and mesh in reconstructive surgeries. Communicative & integrative biology 15 (1) (2022)
Kunihiro Asanuma, Tomoki Nakamura, Takahiro Iino, Tomohito Hagi, Akihiro Sudo
Macrophages and vimentin in tissues adjacent to megaprostheses and mesh in reconstructive surgeries. Communicative & integrative biology 15 (1) (2022)
Tomoki Nakamura, Tomohito Hagi, Kunihiro Asanuma, Akihiro Sudo
Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma? Cancers 14 (21) (2022)
Kunihiro Asanuma, Tomoki Nakamura, Koichi Nakamura, Tomohito Hagi, Takayuki Okamoto, Kouji Kita, Yumi Matsuyama, Keisuke Yoshida, Kunihiro Asanuma, Akihiro Sudo
Compound Library Screening for Synergistic Drug Combinations: mTOR Inhibitor and Proteasome Inhibitor Effective Against Osteosarcoma Cells. Anticancer research 42 (9) (2022)
Tomoki Nakamura, Kunihiro Asanuma, Motoshi Takao, Takashi Yamanaka, Hiroshi Koike, Toyofumi F Chen-Yoshikawa, Satoshi Tsukushi, Hiroaki Kuroda, Eiji Kozawa, Masaaki Sano, Hisaki Aiba, Ryoichi Nakanishi, Akihito Nagano, Kenji Yamada, Yoji Shido, Katsuhisa Kawanami, Yuya Izubuchi, Akihiro Sudo, Yoshihiro Nishida
Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study. Cancer management and research 13 (2021)
Kunihiro Asanuma, Tomoki Nakamura, Tomohito Hagi, Takayuki Okamoto, Kouji Kita, Koichi Nakamura, Yumi Matsuyama, Keisuke Yoshida, Yumiko Asanuma, Akihiro Sudo
Significance of coagulation and fibrinolysis markers for benign and malignant soft tissue tumors. BMC cancer 21 (1) (2021)
Kunihiro Asanuma, Tomoki Nakamura, Yumiko Asanuma, Takayuki Okamoto, Takuya Kakimoto, Yuki Yada, Tomohito Hagi, Kouji Kita, Koichi Nakamura, Akihiko Matsumine, Akihiro Sudo
Prognostic Significance of Thrombomodulin mRNA in High-Grade Soft Tissue Sarcomas after 10 years. Orthopaedic surgery 12 (6) (2020)
Tomoki Nakamura, Jun Sugaya, Norifumi Naka, Hiroshi Kobayashi, Tomotake Okuma, Toshiyuki Kunisada, Kunihiro Asanuma, Hedetatsu Outani, Shunji Nishimura, Hiroyuki Kawashima, Toru Akiyama, Taketoshi Yasuda, Shinji Miwa, Akihiro Sudo, Takafumi Ueda
Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group. Cancer management and research 12 (2020)
Tomoki Nakamura, Kunihiro Asanuma, Tomohito Hagi, Akihiro Sudo
Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan. Drug design, development and therapy 14 (2020)